Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Jill Winter"'
Autor:
Annabelle Cottam, Ismaila L. Manneh, Awa Gindeh, Abdou K. Sillah, Ousainou Cham, Joseph Mendy, Amadou Barry, Edward G. Coker, Georgetta K. Daffeh, Simon Badjie, Salieu Barry, Olumuyiwa Owolabi, Jill Winter, Gerhard Walzl, Jayne S. Sutherland
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundTuberculosis (TB) and COVID-19 are the two leading causes of infectious disease mortality worldwide, and their overlap is likely frequent and inevitable. Previous research has shown increased mortality in TB/COVID-coinfected individuals, an
Externí odkaz:
https://doaj.org/article/707c836fc41647a7bf92659d617f3291
Autor:
Stephanus T. Malherbe, Ray Y. Chen, Patrick Dupont, Ilse Kant, Magdalena Kriel, André G. Loxton, Bronwyn Smith, Caroline G. G. Beltran, Susan van Zyl, Shirely McAnda, Charmaine Abrahams, Elizna Maasdorp, Alex Doruyter, Laura E. Via, Clifton E. Barry, David Alland, Stephanie Griffith- Richards, Annare Ellman, Thomas Peppard, John Belisle, Gerard Tromp, Katharina Ronacher, James M. Warwick, Jill Winter, Gerhard Walzl
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-15 (2020)
Abstract Background There is a growing interest in the use of F-18 FDG PET-CT to monitor tuberculosis (TB) treatment response. Tuberculosis lung lesions are often complex and diffuse, with dynamic changes during treatment and persisting metabolic act
Externí odkaz:
https://doaj.org/article/5d6e9e74073f4ab0a71f8f008e07ff38
Autor:
Stuart Meier, James A Seddon, Elizna Maasdorp, Léanie Kleynhans, Nelita du Plessis, Andre G Loxton, Stephanus T Malherbe, Daniel E Zak, Ethan Thompson, Fergal J Duffy, Stefan H E Kaufmann, Tom H M Ottenhoff, Thomas J Scriba, Sara Suliman, Jayne S Sutherland, Jill Winter, Helena Kuivaniemi, Gerhard Walzl, Gerard Tromp, GC6-74 Consortium, Catalysis TB Biomarkers Consortium
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0278295 (2022)
Mycobacterium tuberculosis (M.tb) causes tuberculosis (TB) and remains one of the leading causes of mortality due to an infectious pathogen. Host immune responses have been implicated in driving the progression from infection to severe lung disease.
Externí odkaz:
https://doaj.org/article/a9c3c19a74ea47aa90537128b591d9f8
Autor:
Trust Odia, Stephanus T. Malherbe, Stuart Meier, Elizna Maasdorp, Léanie Kleynhans, Nelita du Plessis, Andre G. Loxton, Daniel E. Zak, Ethan Thompson, Fergal J. Duffy, Helena Kuivaniemi, Katharina Ronacher, Jill Winter, Gerhard Walzl, Gerard Tromp, the Catalysis TB-Biomarker Consortium, André G. Loxton, Annare Ellman, Bronwyn Smith, Caroline G. G. Beltran, Clifton E. Barry, David Alland, Friedrich Thienemann, James M. Warwick, Kim Stanley, Ilse Kant, Lani Thiart, Lance A. Lucas, Laura E. Via, Lori E. Dodd, Magdalena Kriel, Nelita Plessis Du, Patrick Dupont, Ray Y. Chen, Robert J. Wilkinson, Shubhada Shenai, Stephanie Griffith-Richards
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Pulmonary tuberculosis (PTB) is characterized by lung granulomas, inflammation and tissue destruction. Here we used within-subject peripheral blood gene expression over time to correlate with the within-subject lung metabolic activity, as measured by
Externí odkaz:
https://doaj.org/article/70919f9b260c42568cd12c831dc3bbde
Autor:
Caroline G. G. Beltran, Tiaan Heunis, James Gallant, Rouxjeane Venter, Nelita du Plessis, Andre G. Loxton, Matthias Trost, Jill Winter, Stephanus T. Malherbe, Bavesh D. Kana, Gerhard Walzl
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Mycobacterium tuberculosis (Mtb) is extremely recalcitrant to antimicrobial chemotherapy requiring 6 months to treat drug-sensitive tuberculosis (TB). Despite this, 4–10% of cured patients will develop recurrent disease within 12 months after compl
Externí odkaz:
https://doaj.org/article/6bd9a4d3ba2645f4aa8877ca4078e26b
Autor:
Stephanus T. Malherbe, Patrick Dupont, Ilse Kant, Petri Ahlers, Magdalena Kriel, André G. Loxton, Ray Y. Chen, Laura E. Via, Friedrich Thienemann, Robert J. Wilkinson, Clifton E. Barry, Stephanie Griffith-Richards, Annare Ellman, Katharina Ronacher, Jill Winter, Gerhard Walzl, James M. Warwick, the Catalysis Biomarker Consortium
Publikováno v:
EJNMMI Research, Vol 8, Iss 1, Pp 1-14 (2018)
Abstract Background There is a growing interest in the use of 18F-FDG PET-CT to monitor tuberculosis (TB) treatment response. However, TB causes complex and widespread pathology, which is challenging to segment and quantify in a reproducible manner.
Externí odkaz:
https://doaj.org/article/1f9bb2af447e42cc8e1a43a7b0bd78d0
Autor:
Ray Y. Chen, Laura E. Via, Lori E. Dodd, Gerhard Walzl, Stephanus T. Malherbe, André G. Loxton, Rodney Dawson, Robert J. Wilkinson, Friedrich Thienemann, Michele Tameris, Mark Hatherill, Andreas H. Diacon, Xin Liu, Jin Xing, Xiaowei Jin, Zhenya Ma, Shouguo Pan, Guolong Zhang, Qian Gao, Qi Jiang, Hong Zhu, Lili Liang, Hongfei Duan, Taeksun Song, David Alland, Michael Tartakovsky, Alex Rosenthal, Christopher Whalen, Michael Duvenhage, Ying Cai, Lisa C. Goldfeder, Kriti Arora, Bronwyn Smith, Jill Winter, Clifton E. Barry III, Predict TB Study Group
Publikováno v:
Gates Open Research, Vol 1 (2017)
Background: By the early 1980s, tuberculosis treatment was shortened from 24 to 6 months, maintaining relapse rates of 1-2%. Subsequent trials attempting shorter durations have failed, with 4-month arms consistently having relapse rates of 15-20%. On
Externí odkaz:
https://doaj.org/article/2e9744f070dd42cc8f0373c77478494c
Autor:
Shubhada Shenai, Katharina Ronacher, Stefanus Malherbe, Kim Stanley, Magdalena Kriel, Jill Winter, Thomas Peppard, Charles E Barry, Jing Wang, Lori E Dodd, Laura E Via, Clifton E Barry, Gerhard Walzl, David Alland
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160062 (2016)
Biomarkers are needed to monitor tuberculosis (TB) treatment and predict treatment outcomes. We evaluated the Xpert MTB/RIF (Xpert) assay as a biomarker for TB treatment during and at the end of the 24 weeks therapy.Sputum from 108 HIV-negative, cult
Externí odkaz:
https://doaj.org/article/3b4244efac984fadae2e704b9d4bf604
Both novices and experts will benefit from this insightful step-by-step discussion of phage display protocols.Phage Display of Peptides and Proteins: A Laboratory Manual reviews the literature and outlines the strategies for maximizing the successful
Autor:
Stephanus T. Malherbe, James Gallant, Jill Winter, Nelita du Plessis, Andre G. Loxton, Bavesh D. Kana, Tiaan Heunis, Gerhard Walzl, Matthias Trost, Rouxjeane Venter, Caroline G. G. Beltran
Publikováno v:
Beltran, C G G, Heunis, T, Gallant, J, Venter, R, du Plessis, N, Loxton, A G, Trost, M, Winter, J, Malherbe, S T, Kana, B D & Walzl, G 2020, ' Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy ', Frontiers in Cellular and Infection Microbiology, vol. 10, 443, pp. 1-14 . https://doi.org/10.3389/fcimb.2020.00443
Frontiers in Cellular and Infection Microbiology, 10:443, 1-14. Frontiers Media
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Frontiers in Cellular and Infection Microbiology, 10:443, 1-14. Frontiers Media
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Mycobacterium tuberculosis (Mtb) is extremely recalcitrant to antimicrobial chemotherapy requiring 6 months to treat drug-sensitive tuberculosis (TB). Despite this, 4–10% of cured patients will develop recurrent disease within 12 months after compl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5197f271c41d94d7d0851796f23b554
https://research.vu.nl/en/publications/b522b3c4-8c1b-43b9-9043-8b4e73499769
https://research.vu.nl/en/publications/b522b3c4-8c1b-43b9-9043-8b4e73499769